DTNBP1 Antibody, FITC conjugated

1. Multilevel ex vivo and in vivo analyses in postmortem brains demonstrate that interaction between antipsychotics and dysbindin-1 is mediated by an imbalance between the short and long isoforms of dopamine D2 receptors, leading to enhanced presynaptic D2 function within the prefrontal cortex. PMID:29891954
2. Our results suggest that DTNBP1 and NRN1 genes show a joint effect on the risk for schizophrenia spectrum disorders. Although the precise mechanism underlying this effect is unclear, the fact that these genes have been involved in synaptic maturation, connectivity and glutamate signalling suggests that our findings could be of value as a link to the schizophrenia aetiology. PMID:27855309
3. Study analyzed human-specific dysbindin-1B expression in multiple brain areas in mouse models and showed that dysbindin-1B exerts a dominant-negative effect on the BLOC-1 complex; this effect may lead to cognitive impairment. PMID:27421225
4. This study demonstrated that BDNF and dysbindin-1 linked to risk for schizophrenia function together to regulate interneuron development and cortical network activity. PMID:26386481
5. This is the first study to suggest that known and newly described polymorphisms in COMT, BDNF, and DTNBP1, genes associated with executive and memory functions in healthy individuals and other clinical populations may modulate cognitive outcome in patients with brain tumors PMID:27091610
6. Data suggest that, in cardiomyocytes, TRIM32 attenuates activation of SRF signaling and hypertrophy due to dysbindin; TRIM24 promotes these effects. TRIM32 promotes dysbindin degradation; TRIM24 protects dysbindin from degradation. (TRIM = tripartite motif-containing protein; SRF = serum response factor) PMID:28465353
7. In schizophrenia patients, there was a significant association of the rs909706 polymorphism with attention and a nonsignificant trend for set-shifting. The other SNPs and haplotypes were not associated with cognitive function. PMID:27798936
8. Authors report the examination of DNA methylation status of DTNBP1 promoter region, one of the most credible candidate genes affected in SCZ. PMID:26285059
9. DTNBP1 is likely to play a role in development of auditory related, visual and olfactory hallucinations PMID:25697573
10. dysbindin-1A protein levels are highly regulated in the nucleus and that dysbindin-1A regulates transcription factor NF-kappa B activity to promote the expression of MMP-9 and TNF-alpha PMID:26171858
11. Study demonstrated that dysbindin-1B, rather than dysbindin-1A and dysbindin-1C, has the ability to aggregate PMID:25704251
12. The present findings intransgenic mice expressing human DTNBP1 support the role of dysbindin-1 in psychiatric disorders. PMID:25298178
13. rs3213207 polymorphism may contribute to methamphetamine-induced panic disorder PMID:25303981
14. Findings add further evidence suggesting an association between dysbindin gene variability and cognitive abnormalities in schizophrenia. PMID:25530342
15. dysbindin-1 formed a protein complex with HDAC3 in human neuroblastoma cells PMID:25196196
16. DISC1 forms a complex with dysbindin and increases its stability in association with a reduction in ubiquitylation. PMID:25635053
17. In homozygotes and heterozygotes of risk allele (CC) of DTNBP1, there was a trend to volumetric reductions in brain regions, regardless of schizophrenia diagnosis. PMID:25042954
18. loss of function mutations in the genes encoding dysbindin and its interacting BLOC-1 subunits PMID:24713699
19. These data confirm at the level of mouse working memory and human working memory-associated physiology a genetic interaction between COMT and DTNBP1. PMID:24145376
20. Mecp2 regulates the expression of components belonging to the dysbindin interactome PMID:23750231
21. Letter/Case Report: report novel HPS7 mutation causing Hermansky-Pudlak syndrome. PMID:23364359
22. The results of this study provided significant effects of the DTNBP1 SNP rs2619522 bilaterally in the hippocampus as well as in the anterior middle frontal gyrus and the intraparietal cortex. PMID:22580710
23. an allele G of DTNBP1 genes may be considered as a marker for higher CR. PMID:23612411
24. study suggests that NMDA receptor-mediated signalling genes, DAO, PPP3CC, DTNBP1 might be involved in schizophrenia pathogenic mechanisms related to gender PMID:23497497
25. the involvement of DTNBP1 not only in the development of attention deficit of schizophrenia, but also in the inter-individual variability of this cognitive domain within the normal functional range. PMID:22911901
26. Results support a role of DTNBP1 gene variants in the glutamate neurotransmission system in the hippocampus which is compatible with growing evidence of a crucial role of glutamate in the pathobiology of schizophrenia PMID:22283763
27. The increased expression of dysbindin might play a role in the pathogenesis of drug-refractory temporal lobe epilepsy. PMID:22337344
28. Dysbindin has been implicated in neurite outgrowth and morphology. Impairments in anatomic connectivity as found associated with the minor Dysbindin allele in our study may result in increased risk for schizophrenia due to altered fiber tracts PMID:22019876
29. associations between rs2619538 and HVA and 5-5-hydroxyindoleacetic acid concentrations were significant; results suggest genetic variation in DTNBP1 gene affects regulation of dopamine and serotonin turnover in CNS PMID:21295953
30. Our results suggest that genetic variation in DTNBP1 is associated with differences in gray and white matter; and that these effects are already evident in children as young as 10-12 years. PMID:21639861
31. Dysbindin-1 gene expression in immortalized lymphocytes from patients with schizophrenia PMID:21512575
32. Cellular, tissue, and system neurological phenotypes from dysbindin deficiencies individuals affected with schizophrenia, emerge from abnormalities in few core cellular mechanisms controlled by BLOC-1-dysbindin-containing complex. PMID:21520000
33. The results of this study provided support for dysbindin (DTNBP1) gene variation, particularly SNPs rs1997679 and rs9370822, to be associated with the clinical phenotype of psychotic depression PMID:20951386
34. These findings confirm the role of the dysbindin-1 gene in the risk for functional psychosis and show a differential haplotypic risk pattern in families with early as opposed to adult onset in the affected offspring. PMID:21305691
35. This study determined whether synaptic reductions of Dysbindin-1 are isoform-specific. PMID:21390302
36. dysbindin haplotype was associated with structural differences in the medial orbitofrontal cortex PMID:21184829
37. The results of this study suggested that variability in a noncoding sequence of DTNBP1 contributes to individual differences in emotional working memory. PMID:20010894
38. Genetic variation in DTNBP1 modestly influences general cognitive ability. PMID:21130223
39. Results showed that these two SNPs in DTNPB1 gene were not related to clinical phenotypes such as melancholia, age at onset, suicidality and co-morbid anxiety disorders. PMID:20822372
40. DTNBP1 polymorphic genes are involved in different subprocesses of short-term memory both in normal subjects and in patients with schizophrenia PMID:20683774
41. No associations were detected for any of the symptom factors indicating that the dysbindin risk haplotype does not predispose to a particular group of symptoms in schizophrenia PMID:19760674
42. Data suggest that DTNBP1 is a good candidate for schizophrenia risk and rs9370822 is either functionally important or in disequilibrium with a functional SNP. PMID:20615671
43. Our results identified the impact of DTNBP1 on the development of a specific attention deficit via modulation of a left prefrontal network. PMID:20846375
44. the nucleocytoplasmic shuttling of dysbindin-1 regulates synapsin I expression and thus may be involved in the pathogenesis of schizophrenia. PMID:20921223
45. This study is the first to report an association of a frequent variant of the DTNBP1 gene (AG/GG of rs2619528) with an electrophysiological measure of prefrontal brain function in patients with schizophrenia. PMID:20180862
46. suggests that there is a common underlying molecular defect involving DTNBP1 that contributes to the development of several anxiety and addictive disorders that are generally recognised as separate clinical conditions PMID:20615259
47. Results identify a distinct, and potentially widespread function of dysbindin in promoting the sorting of specific GPCRs to lysosomes after endocytosis. PMID:20174469
48. To investigate dysbindin function in the brain could shed light on the etiology of schizophrenia and lead us to new hypotheses, novel diagnostic tools, and more effective therapies for the disorder PMID:20666140
49. DTNBP1 variations are possibly associated with some symptoms of schizophrenia, which could partly explain the relationship between the susceptibility gene DTNBP1 and that disease PMID:20598229
50. This study could not replicate previous association findings between Dysbindin and in schizophrenia one of the largest European samples to date. PMID:20083391

Show More

Hide All

[Isoform 1]: Cytoplasm. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Melanosome membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse, postsynaptic density. Endoplasmic reticulum. Nucleus. Note=Mainly cytoplasmic but shuttles between the cytoplasm and nucleus. Exported out of the nucleus via its NES in a XPO1-dependent manner. Nuclear localization is required for regulation of the expression of genes such as SYN1. Detected in neuron cell bodies, axons and dendrites. Mainly located to the postsynaptic density. Detected at tubulovesicular elements in the vicinity of the Golgi apparatus and of melanosomes. Occasionally detected at the membrane of pigmented melanosomes in cultured melanoma cells. The BLOC-1 complex associates with the BLOC-2 complex in early endosome-associated tubules.; [Isoform 2]: Cytoplasm. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Melanosome membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse, postsynaptic cell membrane. Endoplasmic reticulum. Nucleus. Note=Shuttles between the cytoplasm and nucleus. Exported out of the nucleus via its NES in a XPO1-dependent manner. Nuclear localization is required for regulation of the expression of genes such as SYN1. Mainly expressed in the dendritic spine. Predominantly a synaptic vesicle isoform but also highly expressed in the nucleus. The BLOC-1 complex associates with the BLOC-2 complex in early endosome-associated tubules. Associated with the AP-3 complex at presynaptic terminals.; [Isoform 3]: Cytoplasm. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Endosome membrane; Peripheral membrane protein; Cytoplasmic side. Melanosome membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse, postsynaptic cell membrane. Endoplasmic reticulum. Note=Exclusivley cytoplasmic. Predominantly found in the postsynaptic density (PSD). Little association with synaptic vesicles. The BLOC-1 complex associates with the BLOC-2 complex in early endosome-associated tubules. Associated with the AP-3 complex at presynaptic terminals.

Dysbindin family

Detected in brain, in neurons and in neuropil. Isoform 1 is expressed in the cerebral cortex, and hippocampal frontal (HF). Specific expression in the posterior half of the superior temporal gyrus (pSTG). Higher expression of isoform 2 and 3 in the HF tha

HGNC: 17328

UNIGENE: Hs.571148

KEGG: hsa:84062

STRING: 9606.ENSP00000341680

OMIM: 607145